Expert Patient Capacity Building Update

Canadians with NMD, their families, and advocates are increasingly asked to take an active role in research initiatives. Research and advocacy training empowers patients and ensures they have the confidence and knowledge needed to share their expertise to guide discussions and inform decisions regarding health care, research, and therapy development for policy makers, industry, and scientists.

 

The NMD4C is involved in several activities under the provision of our Training and Education initiatives, including the establishment of expert patient capacity building (EPCB) resources for Canadian NMD patients. The EPCB team’s work involves the promotion of patient engagement in all aspects of NMD, and the development of easy-to-use and accessible Canadian NMD training modules and resources for both patients and researchers to support patient-oriented neuromuscular research in Canada.

 

To facilitate the network’s EPCB activities, the NMD4C is excited to announce the hiring of Patricia Mortenson, who has joined this team as project coordinator.

Read Patricia’s full bio here!

 

To assist in the development of modules to train patients and researchers to partner effectively, the EPCB team is reviewing the Canadian research landscape to find current resources and programs. Throughout all EPCB work, the team will utilize the Strategy for Patient-Oriented Research (SPOR) Patient Engagement Framework developed by CIHR. This framework allows patients to provide knowledge and input drawn from their unique experience gained through living with a condition or illness, and their first-hand experience in navigating treatments and the Canadian health care system.

The NMD4C encourages you to share any relevant expert patient capacity building resources that you know of with our team!

If you are a researcher who has experience in working with expert patients, we would also love to hear from you!

 

Please complete this short 5-minute survey here!

image from https://fshoq.com/

Read next...

Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy.

Muscular Dystrophy Canada Launches Initiative to Improve Genetic Testing Access for Myotonic Dystrophy

Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy.

LEARNMD content update - February 2025

New Content Available in LEARNMD

LEARNMD is the NMD4C’s online educational platform, offering talks and sessions on a wide range of neuromuscular topics presented by leading clinical and scientific experts worldwide. We’re excited to share what’s new on LEARNMD in February 2025!

RQAS logo

Quebec Network RĂ©seau QuĂ©bĂ©coise de l’Amyotrophie Spinale Joins NMD4C as Community of Practice Sub-Group

We are thrilled to announce that the RQAS, a network uniting rehabilitation clinicians across Quebec to advance the care of people with Spinal Muscular Atrophy has officially become a sub-group Community of Practice of the NMD4C

2024 year in review

NMD4C 2024 Year in Review

This year in review outlines a collection of achievements from the network over the past year.

2025 NM fellowship funding recipients

NMD4C and MDC Award Fellowship Funding in NMD Research and Medicine

Together the Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC) are excited to announce the 2025 recipients of our neuromuscular fellowship funding competition to award postdoctoral fellowships in neuromuscular disease (NMD) research and clinical fellowships in neuromuscular medicine and electromyography!

Meet the Basic Science Trainee Committee

NMD4C Basic Science Trainee Committee Provides Leadership Opportunity for Next Generation of Neuromuscular Researchers

The newly-formed Basic Science Trainee Committee represents the interests of trainees within the network, offering an opportunity for professional growth for future leaders in neuromuscular research.